The Effect of Day-Night Cycle on the Transition Time to Full Enteral Feeding in Preterm Newborns Receiving Oropharyngeal Colostrum
Launched by BIRUNI UNIVERSITY · Mar 17, 2025
Trial Information
Current as of April 23, 2025
Completed
Keywords
ClinConnect Summary
This study was conducted to determine the effect of day-night cycle on the transition of premature newborns receiving oropharyngeal colostrum to full enteral nutrition. The data of the study, which was conducted in a randomized controlled experimental research design between May and December 2022, were collected in the Neonatology Clinic of a university-affiliated training and research hospital in Istanbul after ethical permissions were obtained. The Neonatology Clinic is a level three Neonatal Intensive Care Unit (NICU) and has the capacity to provide specialized care for premature infants...
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • Those born between 28-32 weeks of gestation.
- • Infants of parents who agreed to participate in the study.
- • Major congenital anomaly, severe systemic disease, necrotizing enterocolitis presence, presence of suspected or confirmed sepsis, birth asphyxia (cord pH / 29 Newborns without arterial pH \<7.0).
- • Neonates admitted to the NICU at ≤ 24 hours of age.
- Exclusion Criteria:
- • babies excluded from the inclusion criteria for this study
About Biruni University
Biruni University is a leading academic institution dedicated to advancing healthcare through innovative research and education. With a strong emphasis on clinical trials, the university collaborates with multidisciplinary teams to conduct rigorous studies that contribute to medical knowledge and improve patient outcomes. Leveraging state-of-the-art facilities and a commitment to ethical research practices, Biruni University aims to foster scientific discovery and translate findings into practical applications in the healthcare field. Through its clinical trial initiatives, the university plays a pivotal role in shaping the future of medicine and enhancing community health.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Istanbul, Zeytinburnu, Turkey
Patients applied
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported